Correlation Between GlaxoSmithKline PLC and Apple Rush

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Apple Rush at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Apple Rush into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Apple Rush, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Apple Rush and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Apple Rush. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Apple Rush.

Diversification Opportunities for GlaxoSmithKline PLC and Apple Rush

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Apple is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Apple Rush in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apple Rush and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Apple Rush. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apple Rush has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Apple Rush go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Apple Rush

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Apple Rush. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 6.62 times less risky than Apple Rush. The stock trades about -0.25 of its potential returns per unit of risk. The Apple Rush is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  0.39  in Apple Rush on August 28, 2024 and sell it today you would lose (0.12) from holding Apple Rush or give up 30.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.46%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Apple Rush

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Apple Rush 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apple Rush has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

GlaxoSmithKline PLC and Apple Rush Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Apple Rush

The main advantage of trading using opposite GlaxoSmithKline PLC and Apple Rush positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Apple Rush can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apple Rush will offset losses from the drop in Apple Rush's long position.
The idea behind GlaxoSmithKline PLC ADR and Apple Rush pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
CEOs Directory
Screen CEOs from public companies around the world